KP Tissue Inc. (KPT) Earnings Call Transcript & Summary
August 13, 2026
Earnings Call Speaker Segments
Operator
operatorMorning, everyone, and thanks for joining us for the KP Tissue Second Quarter 2026 Results Conference Call. This call is being recorded so it can be replayed later. Right now, all participants are in listen-only mode. After the presentation, there will be a question-and-answer session. At that point, we'll give you instructions on how to queue up for questions. Should you have any trouble hearing the conference at any point, just press * then 0 and an operator will assist you. At this time, I'll hand the call over to Doris Grbic, Director of Investor Relations. Please go ahead with your conference.
Doris Grbic
executiveThank you, operator. Good morning, everyone, and thanks for being with us as we go through Kruger Products' second quarter 2026 financial results. Joining me this morning are Dino Bianco, CEO of KP Tissue and Kruger Products, and Michael Keays, CFO of KP Tissue and Kruger Products. Certain forward-looking statements will be part of today's discussion. Because of known and unknown risks and uncertainties, actual results could differ materially from those forward-looking statements. Our public filings contain a list of risk factors. Today's discussion will also include certain non-GAAP financial measures. You can find the reconciliation of these non-GAAP financial measures to the most comparable GAAP measure in our MD&A. The press release reporting our Q2 2026 results was published this morning, and it will be available on our website at kptissueinc.com. Our website and SEDAR+ will also host the financial statements and MD&A. The investor presentation that accompanies today's discussion is available in the Investor Relations section of our website. I will now turn the call over to our CEO, Dino Bianco. Dino?
Dino Bianco
executiveThank you, Doris. Good morning, everyone, and thanks for being with us on our second quarter earnings call for fiscal 2026. In the second quarter of 2026, we kept up strong momentum, with adjusted EBITDA rising by double digits year-over-year to $90.6 million. That increase, delivered despite an uncertain economic environment, came primarily from greater sales volume in the U.S. as well as lower pulp prices. Revenue was up almost 3% during the second quarter, driven by robust growth in our away-from-home business. As we look toward the second half of 2026, we expect continued softness in the Canadian consumer market, with certain consumers trading down to private label products as they grapple with inflationary pressure. A trademark recovery plan has been implemented for the second half of 2026, and it ought to produce improving shares as the year progresses. In light of the tariff announcements made recently that affect North America, we do not anticipate a significant impact on our business. We will keep watching closely for the effects of possible tariffs and will put contingency plans in place to mitigate any related financial risk. Over the longer term, we are advancing toward securing a preferred location for a new TAD facility in the Western United States.
Dino Bianco
executiveLet's dig into the quarterly figures on slide six a bit more. As we noted earlier, adjusted EBITDA came in above $90 million for the second quarter of 2026. That's a 25% increase compared with a year ago, on revenue of $550.9 million. Canadian revenue fell 2.6% during the second quarter, which mirrors the softer market conditions I referenced earlier. Worth pointing out too that Canada faces a tough comparison, since second-quarter 2025 sales there grew 7.4%, or $20.7 million, helped by solid Made in Canada initiatives and promotion during that year. U.S. revenue stayed strong, with sales up 9.5% in the second quarter of 2026. Turning to slide seven, you'll see pulp average prices in Canadian dollars, which rose from one quarter to the next in the second quarter of 2026. Compared with a year earlier, NBSK average prices dropped 13.4% amid persistent overcapacity, whereas BEK average prices gained 15.2% over that same span. Within the industry, analysts again anticipate that both NBSK and BEK prices will move higher toward the end of 2026 and on into 2027, though BEK is expected to climb more quickly and reach a higher level. Now let's turn to our operations on slide eight.
Dino Bianco
executivePaper machine and converting operation output kept beating our targets throughout the network in Q2 and, more broadly, the first half of the year. It's a real pleasure to keep up both a robust safety culture and robust safety performance as we pass the year's midpoint. Down in Memphis, the new cutting-edge converting line—up and running early in Q2—is moving forward faster than planned, which lets us grow capacity and turn out a broad lineup of premium tissue goods for buyers in the U.S. We're equally glad that the Memphis site is meeting its major safety, productivity, and sustainability targets. Last, as noted before, we're making headway toward picking a new TAD site in the Western United States. Turning now to slide nine, on brand support: through Q2 we kept running equity-building efforts behind Cashmere, SpongeTowels, Scotties, and Bonterra. We likewise drew on our Made in Canada stance with campaigns backing Cashmere and Purex bathroom tissue. Beyond that, we refreshed Cashmere packaging to sharpen brand segmentation across the UltraStrong, UltraSoft, and Original lines, which ought to help shoppers find what they want more easily. In Q2 as well, we introduced our nationally and internationally award-winning Cashmere UltraLuxe Bathroom Guide in Montreal, spotlighting remarkably luxurious restaurant washrooms around the Montreal area.
Dino Bianco
executiveDuring Q2, we rolled out multiple product innovations as well. One was Sponge Napkins Premium, which delivers both premium softness and strength in a napkin. We also broadened our lineup of nature-inspired, plastic-free Bonterra facial tissue boxes, which are created by the Canadian designer and TV personality Sarah Richardson, by adding single-box offerings. Please turn to slide 10. The figures shown come from Nielsen and illustrate how Kruger Products branded market share performed in Canada across a 52-week period that ended June 13, 2026. These numbers mirror a soft Canadian market shaped by inflationary pressures and slower population growth. In addition, we saw some share losses in the bathroom tissue and paper towel categories, with some consumers trading down to private label products. As mentioned earlier, a share recovery plan is now in place for the second half of 2026, and it should deliver improving shares as we move through the year. In facial tissue, we grew our leadership position to 47% of the Canadian market, backed by continued strong investments in our Scotties brand and in innovations. Let's look at the Kruger Pro, or away-from-home, segment on slide 11. In Q2 2026, revenue and volume grew year-over-year, but profitability declined slightly, honestly, because of high transportation costs.
Dino Bianco
executiveEven though both Canada and the United States saw higher volume during the second quarter, growth remained stronger in our U.S. operations than in Canada. Sequentially, Kruger Pro posted gains in revenue, volume, and profitability. In the second quarter, we also announced a price increase aimed at offsetting inflationary pressures on our Kruger Pro business, mainly from higher fuel and transportation costs. In addition, solid operational performance kept supporting sustained growth in the commercial market. At this point, I'll hand the call over to Michael.
Michael Keays
executiveThanks, Dino, and good morning, everyone. If you’d please turn to slide 12, that gives you a summary of how we performed financially in the second quarter of 2026. As Dino noted, adjusted EBITDA came in at $90.6 million for the quarter on sales of $550.9 million, which works out to strong adjusted EBITDA growth of 25% versus a year ago. Net income was $22.1 million in Q2 2026, which is comparable to the second quarter of 2025. The main offset to the higher adjusted EBITDA was an unfavorable foreign exchange difference. Looking at our quarterly segmented view on slide 13, revenue from the consumer business rose 1.9% year-over-year to $457.6 million. That gain came from higher U.S. sales volume, partly offset by a slight decline in Canada. In away-from-home, revenue was up 7.4% year-over-year to $93.3 million, mainly on higher U.S. sales volume. Consumer adjusted EBITDA for the second quarter was $85.3 million versus $69.2 million in Q2 2025, at a margin of 18.6%, an improvement of 3 points over the same period last year. Sequentially, consumer adjusted EBITDA rose by $1.4 million from Q1 2026. In away-from-home, adjusted EBITDA was $8.5 million versus $9 million in Q2 2025, and the margin fell 1 point year-over-year to 9.1%.
Michael Keays
executiveOn a sequential basis, AFH adjusted EBITDA rose by $2.2 million compared with Q1 2026. Turning to slide 14, consolidated revenue for Q2 2026 came in at $550.9 million, a gain of 2.8% versus the prior year. That growth stemmed mainly from stronger U.S. consumer and AFH sales volume, partly offset by weaker consumer volume in Canada. Looking geographically, Canadian revenue fell $7.7 million, or 2.6%, year-over-year, whereas U.S. revenue climbed $22.5 million, or 9.5%. Slide 15 lays out our profitability on a year-over-year basis. Adjusted EBITDA rose $18.1 million to $90.6 million, giving a margin of 16.4% against 13.5% in last year's comparable period. The improvement over the prior year came from better mill performance at the Memphis facility, increased sales volume, and lower pulp prices, partly offset by higher freight costs and increased SG&A expenses. Let's now move to slide 16, which compares Q2 revenue with Q1 2026. Revenue grew $6.3 million sequentially, or 1.1%, driven mainly by higher AFH sales volume. By geography, Canadian revenue was up $3 million, or 1%, while U.S. revenue increased $3.3 million, or 1.3%. On slide 17, adjusted EBITDA rose $3.7 million, or 4.2%, sequentially to $90.6 million, chiefly reflecting lower manufacturing overhead costs, higher AFH sales volume, and reduced marketing expenses.
Michael Keays
executiveThose impacts were partly counterbalanced by greater freight and warehousing costs along with increased SG&A expense. In the second quarter, adjusted EBITDA margin came in at 16.4%, versus 16.0% in Q1 2026. Moving to the balance sheet and financial position on slide 18, cash fell during Q2 2026, landing at $165.2 million, down from $205.9 million when Q1 2026 closed. Working capital movements were the main driver of that reduction. At the close of the second quarter, total debt held steady relative to the end of Q1 2026. Our leverage ratio stood at 2.9 times when the second quarter ended, unchanged from Q1, as growth in net debt was balanced out by stronger adjusted EBITDA across the trailing 12-month span. To wrap up my portion, we'll go over capital expenditures on slide 19. Capex in Q2 2026 came to $15.5 million, versus $16 million in Q1. Capex for 2026 is projected to land between $90 and $110 million, encompassing outlays on associated strategic projects, among them the pre-engineering work tied to our U.S. TAD expansion. Thanks for being with us this morning; I'll hand the call back to Dino now.
Dino Bianco
executiveThanks, Michael. Moving to slide 21 for my closing remarks. We posted robust profitability during the first half of 2026, and we'll stay sharply focused on delivering margins, particularly with input costs and tariffs potentially rising. Our new converting line in Memphis is being ramped up, adding capacity across our U.S. network. We'll keep investing in our brands to drive long-term share, including that share recovery plan I mentioned for the back half. Our Kruger Pro business should keep delivering profitable growth. We're making headway on securing a site for the new TAD tissue plant in the Western United States. We're building organizational capability to bolster our adaptability and resilience amid ongoing economic shifts. Lastly, for the third quarter of 2026, our adjusted EBITDA outlook is expected to fall within the range of our Q2 2026 results. We'll now be glad to take your questions.
Operator
operatorThank you. Ladies and gentlemen, we'll now move to the question-and-answer portion. Should you wish to ask something, press the pound key and then 1 on your touchtone phone. A one-tone prompt will sound to confirm your request. Questions will be polled according to the order in which they arrive. If you'd prefer to withdraw from the polling process, just press the pound key. If you're on a speakerphone, please make sure you lift the handset before pressing any keys. One moment, please, while we take the first question. Your first question is from Ahmed Abdullah with National Bank of Canada. Please go ahead.
Ahmed Abdullah
analystHello, good morning, and thank you for taking my question. Dino, you brought up a plan to recover share in Canada during the second half. Could you give us a little more detail on how that will actually work and what the main levers are behind it? Is it going to need promotional activity and brand investment, and how soon do you think that benefit will show up?
Dino Bianco
executiveAppreciate that question. Around March we experienced some share erosion, and that carried over into April and May. Bathroom tissue and towel are the main areas I'm referring to. Facial has performed well. In June we began seeing a bit of a rebound as certain plans took effect, and we anticipate that recovery will keep going. I suppose it boils down to a few factors, really. To begin with, at certain accounts our pricing had drifted somewhat off target, so we needed to make adjustments to get our price gaps back where they belong. That work is complete. We've engaged with those accounts and presented a category management story showing why the leading brands need to be carried at a price that works for the consumer and works for the customer. That's underway. Thanks to the gaps we experienced, we've also locked in extra promotional support. I'd add that everyone is up against a tough comparison from last year, when Made in Canada resonated very strongly with consumers. That sentiment, I believe, remains, though it isn't at last year's level.
Dino Bianco
executivePart of this is down to lapping comparisons, which is driving some of the share losses. We benefited from that. And finally, we launched a towel product without, probably, enough support in how we communicated its value to consumers. We'll make some adjustments to both our messaging and the product. Will it be expensive? I doubt it. It isn't material. At this stage we're essentially fine-tuning, with a real focus on execution. We're already beginning to see gains, as I mention here in mid-August, and we anticipate continued improvement across the second half.
Ahmed Abdullah
analystUnderstood. That maybe speaks to how durable the consumer margin is. Turning to Memphis, how much progress have you made toward capturing the complete earnings potential of that facility, and what further productivity or cost gains remain for us to see?
Dino Bianco
executiveThat's a great question. I've spoken about Memphis many times. Unfortunately, what I discussed was the turnaround. I couldn't be prouder of everything that whole team has accomplished. I brought up not just the strong performance, but also the sustainability efforts they're making and the work they're doing to keep their people safe. I believe there's a refreshed culture and mindset there, thanks to the leadership and the full team on the ground who now have a winning mentality, and they are delivering on it. On top of that, as we've been investing over the years with capital toward installing new lines, performing maintenance on our lines, and so on, we're making solid progress. I'd say we likely have another year to go before reaching our maturity level. You can see the performance gains coming through the assets. The areas where I'd say we probably need to adjust a bit more: we still spend heavily on maintenance because we've been bringing those assets up to working condition, or base condition. Once that's done, we'll be able to return to normalized maintenance costs, and I think that should also help improve the economics of that site. We're also examining making further investments to boost capacity at that site, so it wouldn't be a particularly large strategic investment, but rather some equipment upgrades that we'd consider making to expand capacity for what I'd describe as very ultra-premium tissue.
Dino Bianco
executiveMemphis has plenty of good developments underway, and in my view the turnaround has already taken place. It is sustainable. Growth will keep coming into view as we move toward 2027.
Ahmed Abdullah
analystAppreciate that. On the TAD facility, it does appear that progress is running somewhat behind what was originally anticipated. Over the coming six months, which milestones ought we to watch for, and when would you anticipate a final investment decision occurring, at which point we could obtain further specifics regarding that project?
Dino Bianco
executiveThat question doesn't really catch me off guard. Thanks for asking it. I'd say things have certainly taken more time than expected, and the way I'd explain that delay is this: to start with, the location we're focused on is a greenfield site. That's the main site under consideration. With any greenfield site, there's considerably more work involved. You've got infrastructure work, water, permitting, roads, rail, waste water — a great deal of work is needed to make sure
Operator
operatorThis conference call is no longer being recorded.
Dino Bianco
executiveHello, can you hear me okay?
Ahmed Abdullah
analystYeah, hello — I haven’t left.
Dino Bianco
executiveI'm not sure what took place there. Someone apparently objected to what I was saying. In any case, there's far more effort involved when you're dealing with a greenfield site—not only for us but also for the specific city or region. I think that's one part of it: getting through all of that and completing the due diligence. We're still doing engineering work and working to lock down financing. The other element that may have caused a bit of a delay, I think, is that we're operating in a highly uncertain economic climate. We'd prefer to have greater clarity about what's happening in the economy before we make a final announcement. Obviously, I mentioned tariffs, where CUSMA stands, and to some degree the knock-on effects of the war in the Middle East. There are simply a great many unknowns, and with an investment of that size, I think we want somewhat more clarity about what's going on in that climate. We remain very committed to the project and very committed to our growth in the United States—we're just doing a bit more due diligence and taking our time. As for a specific timeline, I won't provide a specific date. It depends more on the activity I just described.
Dino Bianco
executiveMy hope is that we'll be able to offer clarity on this before the year is over.
Ahmed Abdullah
analystThat is quite useful. I will hand it over to the next speaker. Thanks a lot.
Dino Bianco
executiveI appreciate that.
Operator
operatorThanks. We'll now take a question from Hamir Patel at CIBC Capital Markets. Go right ahead.
Hamir Patel
analystHello, good morning. Dino, could you put a number on how large the price hikes you've announced in AFH actually are?
Dino Bianco
executiveYes, so we announced a price increase between 3% and 5%, effective September 1st. As I mentioned earlier, the main reason was to offset transportation costs, packaging, and oil-based inputs. That increase is working its way through the system — across both Canada and the United States. Obviously, other companies announced pricing both before and after our announcements, so it seems the market is experiencing similar cost pressures. That price increase covered roughly two-thirds of our business, since the remaining third is generally under contract and renews when those contracts come up. It was more of a broad market increase that we implemented, and as I said, you've likely seen very similar announcements from others.
Hamir Patel
analystThanks. Returning to the consumer business — overall, your Q3 guidance is pretty encouraging, but I know you're working on rebuilding market share. You mentioned sticker prices and that some adjustments may be happening there, but is part of this perhaps about balancing that against de-sheeting and other innovations, so that maybe per-sheet pricing stays relatively stable?
Dino Bianco
executiveWe're examining every bit of that, Hamir. When you're handling a category such as bath tissue in particular, it's crucial that your format stays highly competitive, and having a competitive price point matters a great deal. Ours isn't the cheapest offering on the market, but there is a specific gap we have to preserve, and we simply want to confirm we hold that gap — and no wider than that gap — with every one of our customers across the board. We keep reviewing de-sheeting, we keep reviewing innovation, we keep reviewing product formats, and clearly all the marketing and promotion we run, but we have to get our fundamentals straight. I believe we've collaborated with certain accounts to confirm that balance is in place. As I noted in my prepared remarks, there's also a natural shift, I think, toward some private label items as consumers feel cash-strapped and perhaps move further toward the value side. That's what we're observing, and perhaps we'll promote more of our base or value products and confirm we have an offering for that consumer who wants that price point.
Hamir Patel
analystAll right, that's fair. So, Dino, regarding the guidance, can we reasonably assume that the Q3 outlook incorporates no effect from tariffs? And then, on the tariff topic, the potential 338 — the worst case, roughly speaking — if those were in force for some stretch of time, what share of your volumes would be impacted?
Dino Bianco
executiveAs I believe everyone is still getting their heads around all of this. We're a week and a bit out, though a lot could change between now and then. We're putting mitigating actions in place around some pre-ships, perhaps exploring alternative sourcing. We don't want to set off anything dramatic at this stage, simply because we want to be certain and we understand whether the tariffs are going through and whether there are any changes in how they're going to be implemented. We are doing some mitigating work in advance that I would describe as fairly minor in scope. We've reassured all our customers that there will be no impact to them from this. As for your specific question, we would be looking at less than 1% of our total sales being related to this tariff, and we would continue to manage that down.
Hamir Patel
analystThanks. That's fairly minor. One last item from me — I believe it was around June when Valmet rolled out a new Advantage NTT technology aimed at ultra-premium tissue. For your next mill, are you committed to TAD technology? Regarding this newer NTT variant, would you view it as a possible threat to TAD?
Dino Bianco
executiveNew technologies keep coming along, of course. In my view, TAD is a highly proven technology—it has existed for quite some time and demonstrates its ability to deliver what it delivers. By contrast, we clearly have two of them in our system, and we understand what they do. We've stated internally, and you can certainly see externally, that we will maintain a strong conventional base, and we do have that. We introduced a new LDC machine a couple of years ago in Quebec. We're going to maintain a strong premium base, which is TAD. Those are truly the areas in which we're going to operate. I would prefer to be in the technology we understand and the technology consumers want, and the technology that we know how to operate and the market knows how to operate. For me, that means conventional and TAD.
Hamir Patel
analystAll right, that's fair. That was everything from my side. I'll hand it over now. Thanks, Dino. Thank you.
Operator
operatorThanks. Our following question is from Sean Steuart at TD Cowen. Go right ahead.
Sean Steuart
analystThanks. Morning, everyone. Dino, you mentioned that hardwood pulp has relatively positive momentum compared with softwood, and I was hoping you could remind us how the two split in your furnish, and how much flexibility you have to shift one way or the other as relative price momentum between hardwood and softwood changes.
Dino Bianco
executiveI won't be giving you a precise figure on that, Sean. I realize that's what you're after, but our usage has been shifting increasingly toward BEK. Through the years, we've done considerable reformulation work, genuinely working to figure out which combination of pulp or furnish lets us produce what's required at a table cost. Naturally, there have also been gains in things such as BEK when it comes to its construct and its capacity to substitute for NBSK. We've kept at that effort. Certain of our brands give us some flexibility, and we're able to switch from one to the other based on the arbitrage. I've consistently described us as roughly a 60/40 mix of the two, and that's the range we generally stay within.
Sean Steuart
analystAlright, thank you for that information. I have one more question about the TAD project. I’m grateful for all the specifics you’ve provided regarding the milestones for advancing it. But just to get some background straight, from what I’ve seen in the local press, it seems as though the site has been finalized. Is that accurate, or does some competitive tension remain—one location versus another in the Western U.S.—to keep this moving?
Dino Bianco
executiveMy take is that nothing is final until we announce it as final. Rumors are always floating around. We've examined various sites and will keep doing so. There is a lead site we're working with, though we also have a small group of other sites that satisfy the criteria. Nothing is settled until you hear it from us. Speculation is always plentiful out there. Perhaps that's the best place to leave it.
Sean Steuart
analystAll right, thank you so much.
Dino Bianco
executiveI appreciate that.
Operator
operatorThank you. As a reminder, should you wish to pose a question, please dial the pound key and then 1 on your touchtone phone. A one-tone prompt will confirm that your request has been received. At this point, there are no more questions. I'll now hand the call to Dino Bianco, who will offer closing remarks. Please proceed, sir.
Dino Bianco
executiveThanks very much. That's all from me. I appreciate all of you being on today's call. We're looking forward to talking with you once more when our third quarter results come out. Thanks again, and enjoy the rest of your day.
Operator
operatorThanks. That wraps up today's conference call, everyone. We appreciate you joining us. You can go ahead and disconnect your lines now.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete KP Tissue Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to KP Tissue Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in KP Tissue Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.